ZA201803942B - Novel processes for preparation of integrase inhibitor - Google Patents

Novel processes for preparation of integrase inhibitor

Info

Publication number
ZA201803942B
ZA201803942B ZA2018/03942A ZA201803942A ZA201803942B ZA 201803942 B ZA201803942 B ZA 201803942B ZA 2018/03942 A ZA2018/03942 A ZA 2018/03942A ZA 201803942 A ZA201803942 A ZA 201803942A ZA 201803942 B ZA201803942 B ZA 201803942B
Authority
ZA
South Africa
Prior art keywords
preparation
integrase inhibitor
novel processes
integrase
inhibitor
Prior art date
Application number
ZA2018/03942A
Inventor
Manjinder Singh Phull
Dharmaraj Ramachandra Rao
Dilip Ramdas Birari
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ZA201803942B publication Critical patent/ZA201803942B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2018/03942A 2017-06-13 2018-06-13 Novel processes for preparation of integrase inhibitor ZA201803942B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201721020606 2017-06-13

Publications (1)

Publication Number Publication Date
ZA201803942B true ZA201803942B (en) 2021-05-26

Family

ID=62981290

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2018/03942A ZA201803942B (en) 2017-06-13 2018-06-13 Novel processes for preparation of integrase inhibitor

Country Status (2)

Country Link
WO (1) WO2018229798A1 (en)
ZA (1) ZA201803942B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220144851A1 (en) * 2019-02-07 2022-05-12 Cipla Limited Novel polymorphs of integrase inhibitor
CN110041210A (en) * 2019-05-06 2019-07-23 凯瑞斯德生化(苏州)有限公司 A kind of Bictegravir intermediate and preparation method thereof
WO2020255004A1 (en) * 2019-06-18 2020-12-24 Laurus Labs Limited Process and polymorphic forms of bictegravir and its pharmaceutically acceptable salts or co-crystals thereof
US11248005B2 (en) 2019-07-08 2022-02-15 Lupin Limited Process for preparation of intermediates used for the synthesis of HIV integrase inhibitor
CN111978333B (en) * 2019-09-30 2021-06-18 常州制药厂有限公司 Crystal form A of Bictegravir sodium salt, preparation method and application
WO2022059028A1 (en) * 2020-09-19 2022-03-24 Msn Laboratories Private Limited, R&D Center Novel polymorph of bictegravir sodium and process for preparation thereof
US20240309017A1 (en) * 2021-01-22 2024-09-19 Laurus Labs Limited Processes for purification of bictegravir intermediates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103154004B (en) * 2010-08-05 2016-07-06 盐野义制药株式会社 There is the manufacture method of the compound of hiv integrase inhibitory activity
AU2013361401C1 (en) 2012-12-21 2018-08-09 Gilead Sciences, Inc. Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
TWI744723B (en) 2014-06-20 2021-11-01 美商基利科學股份有限公司 Synthesis of polycyclic-carbamoylpyridone compounds

Also Published As

Publication number Publication date
WO2018229798A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
EP3541932A4 (en) Inhibitors of crispr-cas9
IL272888B1 (en) Novel uses of piperidinyl-indole derivatives
ZA201803942B (en) Novel processes for preparation of integrase inhibitor
EP3602905A4 (en) Indication for portion of time interval
PT3371152T (en) Compositions comprising an inhibitor of lysine specific demethylase-1
HK1256256A1 (en) Pharmaceutical composition comprising a potent inhibitor of urat1
IL257061A (en) Inhibitors of ezh2
GB201521059D0 (en) Inhibitors of metallo-beta-lactamases
EP3376870A4 (en) Process for the preparation of kinase inhibitors and intermediates thereof
GB201708457D0 (en) Inhibitors of metallo-beta-lactamases
PL3717457T4 (en) Process for preparation of enzalutamide using novel intermediate
IL269695A (en) Compounds useful as inhibitors of alcat 1
IL267821A (en) Inhibitors of nhe-mediated antiport
IL268835B (en) Process for the preparation of 2-cyanoimidazole compounds
SI3565552T1 (en) An improved process for the preparation of rivaroxaban involving novel intermediate
IL275480A (en) Process for the preparation of pyrimidinyl-4-aminopyrazole compounds
EP3386944A4 (en) Process for preparation of lisdexamphetamine
IL248585A0 (en) Processes and intermediates for the preparation of a pde10 inhibitor
PT3394069T (en) Process for the preparation of hiv integrase inhibitors
GB201708451D0 (en) Inhibitors of metallo-beta-lactamases
AU2016205137B2 (en) Furoquinolinediones as inhibitors of TDP2
ZA202002116B (en) Process for the preparation of piperine
HUE057882T2 (en) Process for the preparation of carbodiimides
IL263363A (en) Polymorph of nintedanib
PT3901141T (en) Novel form of isoquinolinesulfonamide